Calton & Associates’s Labcorp LH Stock Holding History

Calton & Associates’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,417	Closed	-$213K	–	877
2017 Q4	$213K	Buy	+1,417	New	+$187K	0.05%	327

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Calton & Associates's LH Position: Q1 2018 in Review

Calton & Associates sold out of Labcorp (LH) in Q1 2018, closing a stake of 1,417 shares — an estimated $213K sold.

Calton & Associates first reported a position in LH in Q4 2017 and held it in 1 quarter. The position peaked at $213K in Q4 2017. 792 funds tracked by Wall St. Rank hold LH as of Q1 2018.

Calton & Associates reported no remaining Labcorp position as of Q1 2018 after selling out during the quarter.
Calton & Associates sold 1,417 Labcorp shares in Q1 2018, an estimated $213K.
Calton & Associates first reported a position in Labcorp in Q4 2017 and held it in 1 quarter.
Calton & Associates's Labcorp position peaked at $213K in Q4 2017.
792 funds tracked by Wall St. Rank held Labcorp as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.